GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (LSE:VERS) » Definitions » Pre-Tax Income

Verseon (LSE:VERS) Pre-Tax Income : £-18.96 Mil (TTM As of Jun. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Verseon Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Verseon's pretax income for the six months ended in Jun. 2019 was £-9.94 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2019 was £-18.96 Mil. Verseon's pretax margin was %.


Verseon Pre-Tax Income Historical Data

The historical data trend for Verseon's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Pre-Tax Income Chart

Verseon Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Pre-Tax Income
Get a 7-Day Free Trial -5.23 -5.14 -15.61 -15.21 -17.04

Verseon Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.90 -8.62 -7.63 -9.02 -9.94

Competitive Comparison of Verseon's Pre-Tax Income

For the Biotechnology subindustry, Verseon's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verseon's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verseon's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Verseon's Pre-Tax Income falls into.



Verseon Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Verseon's Pretax Income for the fiscal year that ended in Dec. 2018 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-17.243+0+-0.211+0.329+0.088999999999995
=-17.04

Verseon's Pretax Income for the quarter that ended in Jun. 2019 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-9.864+0+-0.393+0.128+0.191
=-9.94

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-18.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verseon  (LSE:VERS) Pre-Tax Income Explanation

Verseon's Pretax Margin for the quarter that ended in Jun. 2019 is calculated as

Pretax Margin=Pretax Income/Revenue
=-9.938/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verseon Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Verseon's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Verseon (LSE:VERS) Business Description

Traded in Other Exchanges
N/A
Address
47071 Bayside Parkway, Fremont, CA, USA, 94538
Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.

Verseon (LSE:VERS) Headlines